47 related articles for article (PubMed ID: 10958121)
1. Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593.
Schenk S; Partridge B; Shippenberg TS
Psychopharmacology (Berl); 2000 Jul; 151(1):85-90. PubMed ID: 10958121
[TBL] [Abstract][Full Text] [Related]
2. A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism.
Kim JA; Pollak KA; Hjelmstad GO; Fields HL
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5664-9. PubMed ID: 15064402
[TBL] [Abstract][Full Text] [Related]
3. Effects of the neuropeptide S receptor antagonist RTI-118 on abuse-related facilitation of intracranial self-stimulation produced by cocaine and methylenedioxypyrovalerone (MDPV) in rats.
Bonano JS; Runyon SP; Hassler C; Glennon RA; Stevens Negus S
Eur J Pharmacol; 2014 Nov; 743():98-105. PubMed ID: 25220242
[TBL] [Abstract][Full Text] [Related]
4. Behavioral meaningful opioidergic stimulation activates kappa receptor gene expression.
Teodorov E; Ferrari MF; Fior-Chadi DR; Camarini R; Felício LF
Braz J Med Biol Res; 2012 Oct; 45(10):982-7. PubMed ID: 22641418
[TBL] [Abstract][Full Text] [Related]
5. The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors.
van de Wetering R; Ewald A; Welsh S; Kornberger L; Williamson SE; McElroy BD; Butelman ER; Prisinzano TE; Kivell BM
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375403
[TBL] [Abstract][Full Text] [Related]
6. Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys.
Zamarripa CA; Naylor JE; Huskinson SL; Townsend EA; Prisinzano TE; Freeman KB
Psychopharmacology (Berl); 2020 May; 237(5):1471-1480. PubMed ID: 32006048
[TBL] [Abstract][Full Text] [Related]
7. MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.
Atigari DV; Uprety R; Pasternak GW; Majumdar S; Kivell BM
Neuropharmacology; 2019 May; 150():217-228. PubMed ID: 30768946
[TBL] [Abstract][Full Text] [Related]
8. Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.
Kivell BM; Paton KF; Kumar N; Morani AS; Culverhouse A; Shepherd A; Welsh SA; Biggerstaff A; Crowley RS; Prisinzano TE
Molecules; 2018 Oct; 23(10):. PubMed ID: 30314288
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
[TBL] [Abstract][Full Text] [Related]
10. Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.
Bailey CP; Husbands SM
Expert Opin Drug Discov; 2014 Nov; 9(11):1333-44. PubMed ID: 25253272
[TBL] [Abstract][Full Text] [Related]
11. Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.
Jupp B; Dalley JW
Br J Pharmacol; 2014 Oct; 171(20):4729-66. PubMed ID: 24866553
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A.
Simonson B; Morani AS; Ewald AW; Walker L; Kumar N; Simpson D; Miller JH; Prisinzano TE; Kivell BM
Br J Pharmacol; 2015 Jan; 172(2):515-31. PubMed ID: 24641310
[TBL] [Abstract][Full Text] [Related]
13. Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.
Ranganathan M; Schnakenberg A; Skosnik PD; Cohen BM; Pittman B; Sewell RA; D'Souza DC
Biol Psychiatry; 2012 Nov; 72(10):871-9. PubMed ID: 22817868
[TBL] [Abstract][Full Text] [Related]
14. A single injection of a novel κ opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats.
Morani AS; Schenk S; Prisinzano TE; Kivell BM
Behav Pharmacol; 2012 Apr; 23(2):162-70. PubMed ID: 22293826
[TBL] [Abstract][Full Text] [Related]
15. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.
Tejeda HA; Shippenberg TS; Henriksson R
Cell Mol Life Sci; 2012 Mar; 69(6):857-96. PubMed ID: 22002579
[TBL] [Abstract][Full Text] [Related]
16. Effects of ATPM-ET, a novel κ agonist with partial μ activity, on physical dependence and behavior sensitization in mice.
SUN JF; WANG YH; LI FY; LU G; TAO YM; CHENG Y; CHEN J; XU XJ; CHI ZQ; NEUMEYER JL; ZHANG A; LIU JG
Acta Pharmacol Sin; 2010 Dec; 31(12):1547-52. PubMed ID: 21102484
[TBL] [Abstract][Full Text] [Related]
17. The role of kappa-opioid receptor activation in mediating antinociception and addiction.
Wang YH; Sun JF; Tao YM; Chi ZQ; Liu JG
Acta Pharmacol Sin; 2010 Sep; 31(9):1065-70. PubMed ID: 20729876
[TBL] [Abstract][Full Text] [Related]
18. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.
Wee S; Koob GF
Psychopharmacology (Berl); 2010 Jun; 210(2):121-35. PubMed ID: 20352414
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms.
Rüedi-Bettschen D; Rowlett JK; Spealman RD; Platt DM
Psychopharmacology (Berl); 2010 Jun; 210(2):169-77. PubMed ID: 19859697
[TBL] [Abstract][Full Text] [Related]
20. Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats.
Morani AS; Kivell B; Prisinzano TE; Schenk S
Pharmacol Biochem Behav; 2009 Dec; 94(2):244-9. PubMed ID: 19747933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
